I was trying to help newbies on another forum and posted

New Post Public Reply Private Reply Replies (1) Message Board
petemantx
1,036
I was trying to help newbies on another forum and posted the below but it was deleted as being off-topic. Well done, SS, you A-hole.

For new people checking out IPIX, it has a lot to offer for both traders and investors.

Traders have made a lot of money due to the constant churning in the share price. Forces seem to want to keep the stock price contained but within a range so that money can be made almost daily as the price rises and settles back down at a fast clip. I am not a trader, don't know much about it, but over the years they have been the BIG winners to date.

As for investors, things have been rough for years due to financial concerns (nothing new when talking about a startup biotech with no products yet and drugs taking 10+ years and about $1B to see thru clinical trials) but events have started to move at a dazzling pace in the last 6 months or so and IPIX seems on the verge of finally capitalizing on its megastar drug, Brilacidin. Brilacidin is a synthetic drug, a defensin mimetic, formulated using tens of thousands of hours on super computers so its benefits are many and its drawbacks very small, if even existent.

Brilacidin is now on a pace to possibly cure all, or at least many, of the most severe lower GI tract problems to include Colitis and Crohn's Disease thru the delivery system of a pill. It is on the verge of going to a PhaseIII trial for Oral Mucositis, has already succeeded in a PhaseII antibiotic trial (ABSSSI), and is currently a leading hope to be a treatment or cure for CV19. It has had tests in governmental bio labs that established that it kills the corona virus, works on human kidney tissue in killing CV, and is nearly finished in testing on how it works regarding human lung tissue. Expectations are quite high, extremely high, for this important lung tissue test due to its past trial history. Then it will be ready for use in human CV trials and Brilacidin should become a worldwide household name. The current testing is expected to result in a lot of money (most think in the 10s of millions) granted to IPIX for furher investigation across many fields. Example: The lung testing, when shown successful, should then lead medical authorities to allow Brilacidin to be tested against COPD and Asthma. Its ability to handle CV should also make it a prime candidate as an adjuvant for ALL other virus vaccines, including the flu. To date, it has NEVER met a bacteria in trials it couldn't kill - to include black plague, about 9 different strains of anthrax, etc.

IPIX also has another drug, Kevetrin, that has shown AMAZING results to date in use as a cancer treatment or adjuvant to ALL current cancer treatments. It is the only current drug that has shown it can activate the p53 gene, named the Guardian Angel gene, as it causes the production of the body's natural defensive agents. It needs to be formulated into a pill and currently the pill is about 1/2 way thru tox tests. It is on hold due to lack of funds to proceed further at the current time. But with the expected government grants on the extremely near horizon (most expect grants within a matter of weeks if lung tissue test results are quite good) the Kevetrin pill will be able to be finished and then be put into quite a battery of trials as a stand alone and, more importantly, as an aid to all other current toxic cancer treatments.

The final piece of the puzzle for BOTH Brilacidin and Kevetrin is that besides showing trial results to date of being extremely effective (efficacious), they are also blessed with safety profiles that are so good, having next to NO negative side effects, that they are marvels in the world of medicine today.

Most the boo-hooing you hear on this board is by the traders as they live and die by the daily share price. The true investors you don't hear much from as the trial results speak for themselves. This investment could be the one of a lifetime if things progress as they have been progressing. But then nothing is ever guaranteed so being such a high risk stock be sure that you don't invest what you can't afford to lose.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Corp Caught in Legal Storm; Investors Take Note

Updated Category News Views 87

A Legal Storm Brewing It's like walking into a saloon, expecting a smooth drink, only to find a bar fight breaking out in front of you. That's the scene with Webull Corporation (NASDAQ: BULL) right now. This time, they ain't just shooting the breeze; they're in the line of legal fire. SBS Law, a heavyweight in shareholder rights, is rallying the troops for a class action...

Continue Reading
AMTD IDEA Eyes Third NYC Hotel Amid Uncertain Deals

Updated Category News Views 50

AMTD IDEA's Expansive NYC Hotel Pursuits When it comes to real estate, AMTD IDEA seems to be on a buying spree in the Big Apple. The company is now eyeballing a third hotel in New York City, marking what could be yet another bold move in its strategic expansion. But let's be frank: deals like these come with their fair share of volatility. As it stands, they're in...

Continue Reading
Chord's Zenlytic Move: A Power Play in AI Expansion

Updated Category News Views 100

Chord's Bold Acquisition: Zenlytic Joins the Fold In a gutsy move that’s got folks buzzing, Chord has pulled Zenlytic into its orbit. Announced with a bang on November 3, 2026, this acquisition isn't just some flimsy, seasonal grab. They're doubling down on AI and doubling their revenue while they're at it. Now, brace yourselves: with giants like Verizon, J.Crew,...

Continue Reading
Jennifer Wills Takes Helm as Sole CEO of Kelleher

Updated Category News Views 175

Jennifer Wills Leads Kelleher International Forward There's a fresh breeze blowing through the halls of Kelleher International, the luxury matchmaking firm. Jennifer Wills, a savvy player with her roots in law and finance, has stepped up as the sole CEO. After a decade of busting her chops at the firm, it's high time she's taken the helm. This ain't just a job transition;...

Continue Reading
Ningbo Consensus Drives Global Urban Cooperation Forward

Updated Category News Views 100

At the Heart of Ningbo: A Collaborative Pact Pull up a chair because we're diving into how cities are shaking hands for a future that's open, connected, and buzzing with opportunity. Talk about the 2026 Global Mayors Dialogue in Ningbo — it’s more than just a fancy meet and greet. On November 3, mayors and city reps from 20 places across 15 countries, plus some big...

Continue Reading
Pearson-Westermann Partnership Boosts English Skills in Germany

Updated Category News Views 97

Revolutionizing English Education in Germany Alright, folks, here's the scoop for all you with a toe in education and workforce development. Pearson and Westermann are shaking hands to tackle one of the biggest skills needed in Germany: English proficiency. This might sound like a dry move on the surface, but trust me, it's a game-changer for students and job seekers...

Continue Reading
Elite Academy Takes Bold Step in Ethical AI for Schools

Updated Category News Views 65

Pioneering New Fronts in Education with AI Elite Academic Academy, a stalwart in California's public charter school landscape, has just taken a significant stride forward by stepping into the EDSAFE AI Alliance District Policy Lab. The move, announced in early November 2026, sees Elite diving into the intricate world of artificial intelligence in education, with a pointed...

Continue Reading
Natuvion and PwC's IT Roadbook: A Game-Changer?

Updated Category News Views 55

IT Transformations: A Tough Nut to Crack Transforming IT systems isn't just about plugging in new tech. It's a beast of a task, fraught with pitfalls and peopled with ambitious project managers hoping to dodge them. Natuvion and PricewaterhouseCoopers (PwC) have put together a book that could be the guide folks need when wading into these complex waters. The 'Why' of...

Continue Reading
Hydden Welcomes Cybersecurity Veteran Charles Tango as CSO

Updated Category News Views 83

Unpacking Charles Tango's Move to Hydden Nobody expects cybersecurity to be a stroll in the park, and it looks like Hydden just upped its game by bringing in Charles Tango, a heavyweight turned strategy guru. You might not know him, but this guy's got a track record that shouldn’t be ignored—like a grizzled old prizefighter just itching for a new opponent. A Veteran...

Continue Reading
Smartphone Durability: What Investors Need to Know

Updated Category News Views 79

When a Drop Becomes a Cost-Benefit Analysis As someone who’s been around the block more times than I care to count, here’s a nugget for you: we rarely think about all the little things that could drill a hole in our pockets until they do. Take smartphones, the ubiquitous little beasts we carry everywhere. An accidental drop, one moment you’re butterfingering it in...

Continue Reading

Top 5 Most Recently Viewed Articles

GAC's Commitment to Excellence in National Games Success

Updated Category News Views 116

Driving Success Through Innovation and Local Insight GAC has emerged as a pivotal player in shaping the experiences of athletes and attendees at the National Games. Recently, the event made waves in the Greater Bay Area, where GAC was proud to serve as the exclusive official automotive partner. This collaboration brought forth a range of high-quality vehicles to ensure...

Continue Reading
Cal-Maine Foods, Inc. Schedules Upcoming Second Quarter Results

Updated Category News Views 170

Cal-Maine Foods, Inc. Announces Upcoming Fiscal Results Cal-Maine Foods, Inc. (NASDAQ: CALM) has recently revealed its plan to unveil financial results for the second quarter of fiscal 2025. This announcement is exciting for investors and stakeholders as they await insights into the company’s performance. Important Release Date The release is scheduled for Tuesday,...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 474

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Nova Leap Health Initiates Incentive Stock Option Program

Updated Category News Views 82

Nova Leap Health Corp. Announces Stock Options Grant NOVA LEAP HEALTH CORP. (TSXV: NLH) has recently made a significant move by issuing a variety of stock options aimed at incentivizing its directors, officers, and senior employees. This development is part of the company's strategy to foster growth within the rapidly expanding home health care sector. Details of the...

Continue Reading
Celebrating Culinary Excellence: International Sous Vide Day

Updated Category News Views 107

Cuisine Solutions Celebrates International Sous Vide Day Honoring Global Sous Vide Excellence and the Future of Culinary Innovation Cuisine Solutions (NYSE: CUSI), the global leaders in sous vide since 1971, is excited to celebrate the annual International Sous Vide Day, recognizing years of pioneering efforts that have transformed culinary arts worldwide. What is Sous...

Continue Reading